Ashley E Pincins, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1012 Union St, Bangor, ME 04401 Phone: 207-992-4100 Fax: 207-992-2846 |
Mr. Robert Wayne Cattan Jr., R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 210 State St, Bangor, ME 04401 Phone: 207-947-8369 Fax: 207-947-0894 |
Dr. Sarah Mcgillicuddy Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 226 Union St, Bangor, ME 04401 Phone: 207-942-0515 |
Allison White Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6 Telcom Dr, Bangor, ME 04401 Phone: 802-793-0280 |
Ms. Erika Lynn Bailey, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 417 State St, Suite 130, Bangor, ME 04401 Phone: 207-973-8888 Fax: 207-973-8891 |
Charles Fichera Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 353 Main St, Bangor, ME 04401 Phone: 207-945-6550 |
Katharine Freudenberger Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 47 Haskell Rd, Bangor, ME 04401 Phone: 207-945-9723 |
Ashley Miller, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 70 Bennett St, Bangor, ME 04401 Phone: 207-275-3300 |
Shilpa Nair Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1012 Union St, Bangor, ME 04401 Phone: 207-992-4100 |
Nicole G Atkins, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1012 Union St Ste 1, Bangor, ME 04401 Phone: 207-992-4100 Fax: 207-992-2846 |
Thomas Richard Caron Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 653 Broadway, Bangor, ME 04401 Phone: 207-947-3680 |
Christopher Lord Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 653 Broadway, Bangor, ME 04401 Phone: 207-947-3680 |
Erin Elizabeth Ackley Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 706 Broadway, Bangor, ME 04401 Phone: 207-262-0190 |
Andrew Hanscom, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 60 Longview Dr, Bangor, ME 04401 Phone: 207-945-9977 |
Zachery Deabay, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1012 Union St, Bangor, ME 04401 Phone: 207-945-5247 |
Mindy Anders Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 489 State St, Pharmacy Department, Bangor, ME 04401 Phone: 207-973-7000 |
Elizabeth Rose Connolly, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 711 Broadway, Bangor, ME 04401 Phone: 207-922-3849 |
Jade Herman Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 47 Haskell Rd, Bangor, ME 04401 Phone: 207-947-9723 |
Roger Doucette, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 268 Stillwater Ave, Bangor, ME 04401 Phone: 207-973-6099 |
Riley Godley Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 210 State St, Bangor, ME 04401 Phone: 207-947-8369 |
News Archive
Telik, Inc. today reported financial results for the first quarter ended March 31, 2010. The net loss for the quarter ended March 31, 2010 was $5.3 million, or $0.10 per share, compared with a net loss of $7.7 million, or $0.14 per share, for the same period in 2009.
Pacific Shore Holdings, Inc., today announced the release of the highly anticipated clinical trial results for Burner Balm lip balm. According to lead clinical investigator, Dr. David E. Toomey, who has orchestrated a multitude of clinical trials for some of the top pharmaceutical manufacturers in the United States, "Over a twelve week period, 120 study participants who were overweight participated in the study. The Burner Balm group lost an average of 7 to 9 pounds versus the placebo group who lost an average of 1.43 to 1.64 pounds in the 12 week period.
Hui Feng, MD, PhD, assistant professor of pharmacology and medicine at Boston University School of Medicine, is the recipient of a four-year, $792,000 grant from the American Cancer Society to study why T-cell acute lymphoblastic leukemia (T-ALL) is so aggressive and resistant to treatment.
Schering-Plough Corporation today reported long-term data with vicriviroc, its investigational CCR5 receptor antagonist, from an ongoing, open-label extension of the Phase II VICTOR-E1 study in treatment-experienced HIV-infected patients.
Labopharm Inc. today announced the U.S. Food and Drug Administration (FDA) has approved OLEPTRO(TM) (trazodone hydrochloride) Extended Release Tablets, a novel once-daily formulation of the antidepressant trazodone, for the treatment of major depressive disorder (MDD) in adults. OLEPTRO(TM) utilizes CONTRAMID(R), Labopharm's clinically validated technology that controls the release of active substances within oral medications.
› Verified 9 days ago